NFKB1 and major depressive disorder: In mouse models with depression-like symptoms, blocking the sigma-1 receptor in astrocytes triggers depression-related behaviors through NF-κB-driven neuroinflammation, which is alleviated by sigma-1 receptor agonists (Wang et al., 2024).